BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12499916)

  • 1. Tumor-suppressing pathways in cystic pancreatic tumors.
    Gerdes B; Wild A; Wittenberg J; Barth P; Ramaswamy A; Kersting M; Lüttges J; Klöppel G; Bartsch DK
    Pancreas; 2003 Jan; 26(1):42-8. PubMed ID: 12499916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.
    Moore PS; Sipos B; Orlandini S; Sorio C; Real FX; Lemoine NR; Gress T; Bassi C; Klöppel G; Kalthoff H; Ungefroren H; Löhr M; Scarpa A
    Virchows Arch; 2001 Dec; 439(6):798-802. PubMed ID: 11787853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma.
    Hirabayashi H; Fujii Y; Sakaguchi M; Tanaka H; Yoon HE; Komoto Y; Inoue M; Miyoshi S; Matsuda H
    Int J Cancer; 1997 Nov; 73(5):639-44. PubMed ID: 9398039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.
    Loukopoulos P; Kanetaka K; Takamura M; Shibata T; Sakamoto M; Hirohashi S
    Pancreas; 2004 Oct; 29(3):193-203. PubMed ID: 15367885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma.
    Heinmöller E; Dietmaier W; Zirngibl H; Heinmöller P; Scaringe W; Jauch KW; Hofstädter F; Rüschoff J
    Am J Pathol; 2000 Jul; 157(1):83-92. PubMed ID: 10880379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
    Biankin AV; Biankin SA; Kench JG; Morey AL; Lee CS; Head DR; Eckstein RP; Hugh TB; Henshall SM; Sutherland RL
    Gut; 2002 Jun; 50(6):861-8. PubMed ID: 12010891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of epidermal growth factor receptor and mitogen-activated protein kinase with cystic neoplasms of the pancreas.
    Kuboki Y; Shiratori K; Hatori T; Fujita I; Kimijima A; Yamamoto M; Kobayashi M; Furukawa T
    Mod Pathol; 2010 Aug; 23(8):1127-35. PubMed ID: 20495538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
    Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alterations in DPC4 gene in pancreatic cancers].
    Gu L; Chen J; Cui Q
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):293-5. PubMed ID: 11783110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors.
    Bartsch D; Hahn SA; Danichevski KD; Ramaswamy A; Bastian D; Galehdari H; Barth P; Schmiegel W; Simon B; Rothmund M
    Oncogene; 1999 Apr; 18(14):2367-71. PubMed ID: 10327057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
    Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K
    Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DPC4/Smad4: no mutations, rare allelic imbalances, and retained protein expression in pancreatic endocrine tumors.
    Perren A; Saremaslani P; Schmid S; Bonvin C; Locher T; Roth J; Heitz PU; Komminoth P
    Diagn Mol Pathol; 2003 Dec; 12(4):181-6. PubMed ID: 14639103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical p16INK4a analysis of archival tumors with deletion, hypermethylation, or mutation of the CDKN2/MTS1 gene. A comparison of four commercial antibodies.
    Geradts J; Hruban RH; Schutte M; Kern SE; Maynard R
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):71-9. PubMed ID: 10937052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.
    Chuang SC; Lee KT; Tsai KB; Sheen PC; Nagai E; Mizumoto K; Tanaka M
    World J Surg; 2004 Oct; 28(10):995-1000. PubMed ID: 15573254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-suppressive pathways in pancreatic carcinoma.
    Rozenblum E; Schutte M; Goggins M; Hahn SA; Panzer S; Zahurak M; Goodman SN; Sohn TA; Hruban RH; Yeo CJ; Kern SE
    Cancer Res; 1997 May; 57(9):1731-4. PubMed ID: 9135016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas: a molecular panel correlates with and supplements cytologic diagnosis.
    van Heek T; Rader AE; Offerhaus GJ; McCarthy DM; Goggins M; Hruban RH; Wilentz RE
    Am J Clin Pathol; 2002 May; 117(5):755-65. PubMed ID: 12090425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression.
    Iacobuzio-Donahue CA; Wilentz RE; Argani P; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Am J Surg Pathol; 2000 Nov; 24(11):1544-8. PubMed ID: 11075857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas.
    Semczuk A; Boltze C; Marzec B; Szczygielska A; Roessner A; Schneider-Stock R
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):589-96. PubMed ID: 12920579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.